Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Tumor Registry
研究概览
简要总结
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
详细描述
Primary Objectives
1. To collect data on participants characteristics, disease characterization, pathology and molecular data, treatment, and outcomes for participants with gynecologic mesonephric-like adenocarcinoma (MLA).
Secondary Objectives
- To organize clinical information to support multifaceted queries of participant characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with participant outcome.
- To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients over the age of
- •Patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), mesonephric carcinosarcoma, or mesonephric-like carcinosarcomas.
- •For patients who provide consent, they must speak and/or read English or Spanish.
排除标准
- •Patients with other subtypes of EACs.
- •Patients who are considered cognitively impaired. Assessment will be obtained based on their need of a Legally Authorized Representative.
结局指标
主要结局
Tumor Registry
时间窗: Through study completion; an average of 1 year
The goal of this data collection study is to develop a database (i.e. a registry/repository) of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
次要结局
未报告次要终点